Cipla Board of Directors

Get the latest insights into the leadership at Cipla. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Y K Hamied Chairman
Mr. Umang Vohra Managing Director & Global CEO
Mr. Kamil Hamied Non Exe.Non Ind.Director
Mr. Abhijit Joshi Non Exe.Non Ind.Director
Mr. Adil Zainulbhai Non Exe.Non Ind.Director
Dr. Balram Bhargava Independent Director
Dr. Mandar Vaidya Independent Director
Ms. Maya Hari Independent Director
Mr. P R Ramesh Independent Director
Mr. Robert Stewart Independent Director
Ms. Sharmila Paranjpe Independent Director

Cipla Share price

CIPLA

1589.4

9.10 (0.58%)
NSE
BSE
Last updated on 29 Aug, 2025 | 15:43 IST
BUYSELL
Today's High

1596.40

Today's Low

1567.80

52 Week Low

1335.00

52 Week High

1702.05

The current prices are delayed, login to your account for live prices

Cipla FAQs

The board at Cipla consists of experienced professionals, including Dr. Y K Hamied , Mr. Umang Vohra , and others, overseeing the company’s strategic and corporate governance.

Directors at Cipla are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Y K Hamied is the current chairman at Cipla.

Executive directors at Cipla are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Cipla adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Cipla, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.